Combined intravenous administration of diazoxide and beta-blocking agent in acute treatment of severe hypertension or hypertensive crisis

American Heart Journal ◽

10.1016/0002-8703(82)90280-0 ◽

1982 ◽

Vol 103 (3) ◽

pp. 395-400 ◽

Author(s):

Frans Th.M. Huysmans ◽

Theo A. Thien ◽

Robert A.P. Koene

Keyword(s):

Intravenous Administration ◽

Acute Treatment ◽

Severe Hypertension ◽

Hypertensive Crisis ◽

Blocking Agent ◽

Download Full-text

The therapeutic response in Gorham’s syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression

BMC Research Notes ◽

10.1186/s13104-015-1259-9 ◽

2015 ◽

Vol 8 (1) ◽

Author(s):

Jessica Baud ◽

Abderrahim Lomri ◽

Denis Graber ◽

Andreas Bikfalvi

Keyword(s):

Therapeutic Response ◽

Blocking Agent ◽

Beta Blocking ◽

Flt1 Expression ◽

Gorham’S Syndrome

Download Full-text

Clinical Evaluation of Practolol, a New Cardioselective Beta-blocking Agent in Angina Pectoris

BMJ ◽

10.1136/bmj.2.5706.399 ◽

1970 ◽

Vol 2 (5706) ◽

pp. 399-402 ◽

Author(s):

G. Sandler ◽

G. A. Clayton

Keyword(s):

Angina Pectoris ◽

Clinical Evaluation ◽

Blocking Agent ◽

Download Full-text

Sublingual Nifedipine Compared with Intravenous Hydrallazine in the Acute Treatment of Severe Hypertension in Pregnancy: Potential for Use in Rural Practice

Journal of Obstetrics and Gynaecology Research ◽

10.1111/j.1447-0756.1996.tb00930.x ◽

1996 ◽

Vol 22 (1) ◽

pp. 21-24 ◽

Author(s):

Ravindran Jegasothy ◽

Sri Paranthaman

Keyword(s):

Acute Treatment ◽

Severe Hypertension ◽

Rural Practice ◽

Hypertension In Pregnancy ◽

Sublingual Nifedipine ◽

Download Full-text

The antihypertensive effect of a new beta-blocking agent pindolol compared with chlorthalidone

European Journal of Clinical Pharmacology ◽

10.1007/bf00567005 ◽

1973 ◽

Vol 5 (4) ◽

pp. 210-213 ◽

Author(s):

O. B. Schaffalitzky de Muckadell ◽

F. Gyntelberg

Keyword(s):

Antihypertensive Effect ◽

Blocking Agent ◽

Download Full-text

Is the Beta Blocking Agent Metipranolol able to Reduce the Frequency of Recurrences After Endoscopic Sclerosis because of Bleeding Esophageal Varices?

Experimental and Clinical Hepatology ◽

10.1007/978-94-009-4151-9_15 ◽

1986 ◽

pp. 107-112

Author(s):

K.-J. Paquet ◽

H. Feussner ◽

P. Koussouris

Keyword(s):

Esophageal Varices ◽

Blocking Agent ◽

Bleeding Esophageal Varices ◽

Beta Blocking ◽

Endoscopic Sclerosis

Download Full-text

A radioautographic study on the incorporation of 14C-bupranolol (beta-blocking agent) into the rabbit eye

Histochemistry ◽

10.1007/bf00493253 ◽

1980 ◽

Vol 68 (3) ◽

pp. 237-244 ◽

Author(s):

S. Tsukahara ◽

K. Yoshida ◽

T. Nagata

Keyword(s):

Blocking Agent ◽

Download Full-text

Comparative Renal Effects of Intravenous Administration of Fenoldopam Mesylate and Sodium Nitroprusside in Patients With Severe Hypertension

Archives of Internal Medicine ◽

10.1001/archinte.1989.00390040080016 ◽

1989 ◽

Vol 149 (4) ◽

pp. 870 ◽

Author(s):

William B. White

Keyword(s):

Sodium Nitroprusside ◽

Intravenous Administration ◽

Severe Hypertension ◽

Download Full-text

Prevention of Adrenaline-Induced Metabolic Systemic and Myocardial Alterations by the Beta-Blocking Agent Metipranolol in the Dog

10.1159/000173246 ◽

1981 ◽

Vol 67 (4) ◽

pp. 206-218 ◽

Author(s):

K. Herbaczy&nacute;ska-Cedro ◽

B. Wo&zacute;niewicz ◽

B. Broniszeáºƒska-Ardelt ◽

L. Ceremu&zdot;y&nacute;ski

Keyword(s):

Blocking Agent ◽

Download Full-text

Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.

Heart ◽

10.1136/hrt.40.1.14 ◽

1978 ◽

Vol 40 (1) ◽

pp. 14-21 ◽

Author(s):

C Robinson ◽

J Birkhead ◽

B Crook ◽

K Jennings ◽

D Jewitt

Keyword(s):

Blocking Agent ◽

Beta Blocking ◽

Electrophysiological Effects

Download Full-text

Generalized Convulsions in a Patient Receiving Ultrashort-Acting Beta-Blocker Infusion

Drug Intelligence & Clinical Pharmacy ◽

10.1177/106002808802200608 ◽

1988 ◽

Vol 22 (6) ◽

pp. 484-485 ◽

Author(s):

Gopal Das ◽

Janine C. Ferris

Keyword(s):

Heart Disease ◽

Beta Blocker ◽

Blocking Agent ◽

Literature Survey ◽

Receptor Blocking ◽

Blocking Agents ◽

Beta Receptor ◽

Generalized Seizures ◽

Beta Blocking ◽

Therapeutic Doses

Beta-receptor blocking agents are commonly used to treat patients with heart disease, and generalized seizures due to therapy with these agents are rare. All reported cases of seizures due to beta blocking agents have occurred only in those subjects who ingested large doses of the drugs. We observed generalized convulsions in a patient who was receiving therapeutic doses of an ultrashort-acting beta-blocking agent (esmolol hydrochloride) intravenously. A literature survey and possible mechanisms by which these agents induce seizures are presented.

Download Full-text